Linking these cardiometabolic diseases is a state of low-grade inflammation, with higher cytokines and c-reactive protein levels found in individuals with NAFLD, obesity and type II diabetes. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.